包含5-氯-N-({(5S)-2-氧代-3-[4-(3-氧代-4-嗎啉基)苯基]-1，3-噁唑烷-5-基}甲基)-2-噻吩甲酰胺的藥物劑型

• 收藏
• 分享

专利权人:

BAYER PHARMA AKTIENGESELLSCHAFT

发明人:

BENKE, KLAUS,NEUMANN, HEIKE,MCK, WOLFGANG

申请号：

HK15110431.9

公开号：

HK1209635A

申请日:

2015.10.23

申请国别(地区):

HK

年份:

2016

代理人:

摘要：

The present invention relates to solid orally administrable pharmaceutical administration forms comprising 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide (rivaroxaban, active compound (I)), wherein a partial amount of the active compound (I) is released rapidly and a partial amount is released in a controlled manner (modified, retarded, delayed), and to processes for their preparation, their use as medicaments and their use for the prophylaxis, secondary prophylaxis or treatment of disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/